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Abstract
Pretransplant islet culture is associated with the loss of islet cell mass and insulin
secretory function. Insulin secretion from islet β-cells is primarily controlled by mito-
chondrial ATP generation in response to elevations in extracellular glucose. Coculture
of islets with mesenchymal stromal cells (MSCs) improves islet insulin secretory func-
tion in vitro, which correlates with superior islet graft function in vivo. This study
aimed to determine whether the improved islet function is associated with mitochon-
drial transfer from MSCs to cocultured islets. We have demonstrated mitochondrial
transfer from human adipose MSCs to human islet β-cells in coculture. Fluorescence
imaging showed that mitochondrial transfer occurs, at least partially, through tunnel-
ing nanotube (TNT)-like structures. The extent of mitochondrial transfer to clinically
relevant human islets was greater than that to experimental mouse islets. Human
islets are subjected to more extreme cellular stressors than mouse islets, which may
induce “danger signals” for MSCs, initiating the donation of MSC-derived mitochon-
dria to human islet β-cells. Our observations of increased MSC-mediated mitochon-
dria transfer to hypoxia-exposed mouse islets are consistent with this and suggest
that MSCs are most effective in supporting the secretory function of compromised
β-cells. Ensuring optimal MSC-derived mitochondria transfer in preculture and/or
cotransplantation strategies could be used to maximize the therapeutic efficacy of
MSCs, thus enabling the more widespread application of clinical islet transplantation.
K E YWORD S
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1 | INTRODUCTION
Allogenic islet transplantation offers the possibility of treating a
small subgroup of people with type 1 diabetes (T1D), but the lim-
ited availability of human islet material is a major obstacle to the
more widespread adoption of islet transplantation as a treatment
option for the majority of people with T1D.1 Clinical
transplantation of allogeneic human islets necessitates a short-term
culture period for safety tests, administration of the transplant
recipient to hospital and induction immunotherapy. Unfortunately,
the functional viability of islets is compromised by inflammatory,
oxidative and hypoxic stresses during this period, with cold ischae-
mia time and oxygen supply during pancreas procurement contrib-
uting to extensive islet cell loss.2
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Mouse mesenchymal stromal cells (MSCs) derived from multiple
tissue sources, including kidney, adipose, and bone marrow (BM), have
direct effects on donor islet β-cells to improve their survival and
insulin secretory function during the in vitro culture period prior to
transplantation.3-7 These in vitro findings correlate with persistent
improvements in subsequent islet post-transplantation function
in vivo. Thus, we demonstrated improved graft curative capacity in
streptozotocin-induced diabetic mice transplanted with islets
cocultured with MSCs, whether grafted at the experimental renal sub-
capsular site4 or at the clinically preferred intraportal route.3 We, and
others, have also demonstrated that these findings translate to clini-
cally relevant human islets and human MSCs.5,8,9
MSCs can influence islet function through a variety of mecha-
nisms. We have identified MSC-derived soluble secretory products
that mimic some of the beneficial effects of MSCs in vitro,10,11 and
shown that preculturing islets with a defined cocktail of MSC-
secreted ligands also improved islet graft function in vivo, albeit not
to the same extent seen with MSC coculture.10 MSC-derived extracel-
lular matrix further contributes to the beneficial effects of MSCs on
islet function,8 and a number of studies have highlighted the impor-
tance of direct MSC-islet cell-cell contact for islet functional sur-
vival.4,6,12 Studies in other tissues have also demonstrated the
capacity of MSCs to act as mitochondria donors by transferring func-
tional mitochondria directly to adjacent cocultured cells in inflamma-
tory and ischemic disease settings, resulting in the rescue of aerobic
respiration.13-17 Insulin secretion from β-cells is primarily controlled
by mitochondrial ATP generation in response to elevations in extracel-
lular glucose, and islet oxygen consumption rate (OCR) is a key predic-
tor of islet transplantation outcome.18-20 We have therefore
addressed the hypothesis that the MSC-dependent enhancement of
insulin secretory function3-6,8,10,12,21,22 is associated with mitochon-
drial transfer from MSCs to neighboring islet β-cells.
2 | MATERIALS AND METHODS
2.1 | Human and mouse islet isolation
Human islets were isolated from six nondiabetic donors at the King's
College Hospital Islet Transplantation Unit, with appropriate ethical
approval (LREC 01-082). Islets were maintained in CMRL medium sup-
plemented with 2% human albumin, 4 mM glutamine, 2 mM HEPES
(pH 7.2-7.4), and 10 mM nicotinamide at 37C, 5% CO2 prior to esta-
blishing human MSC: human islet cocultures, which were maintained in
RPMI-1640 (supplemented with 10% [vol/vol] FCS, 2 mmol/L-gluta-
mine, and 100 U/mL penicillin/0.1 mg/mL streptomycin). Human islets
were handpicked into groups of 80 for culture alone or with MSCs for
1-3 days, as specified. The characteristics of each donor (age, gender,
body mass index [BMI], islet purity, and viability) are specified in Sup-
plementary Table S1. Mouse islets were isolated from male CD1 mice
(Charles River, Margate, Kent) aged 8-12 weeks, by collagenase diges-
tion (1 mg/mL; type XI; Sigma-Aldrich, Poole, UK) followed by density
gradient separation (Histopaque-1077; Sigma-Aldrich). After washing
with RPMI-1640 medium, islets were handpicked into groups of 80 for
culture alone or with MSCs for 1-3 days as specified.
2.2 | Direct contact coculture of islets and MSCs
We used a direct-contact monolayer configuration to coculture islets
with MSCs, as previously described.3-5,8 Briefly, 100 000 mouse MSCs
(Cyagen strain C57BL/6 BM-derived MSCs or Cyagen strain C57BL/6
Adipose-derived MSCs; Generon, Slough, UK), or human adipose-derived
MSCs (Stempro Human Adipose-derived stem cells; Life Technologies
Ltd, Paisley, UK) were seeded into Nunclon 35 mm petri dishes, or
35 mm ibitreat ibidi μ-Dish, high (Thistle Scientific Ltd, Glasgow, UK) for
confocal imaging, forming a confluent monolayer of cells within
12 hours. MSCs were cultured in DMEM supplemented with 1%
(vol/vol) penicillin/streptomycin solution (Gibco BRL, Gaithersburg,
Maryland) supplemented with 10% (vol/vol) FCS and incubated at
37C in a humidified atmosphere containing 5% CO2. The medium
was changed after 20 hours, with removal of nonadherent cells.
Eighty isolated islets were then added to each petri dish allowing
direct cell-cell contact between the islets and pre-seeded MSCs. The
medium was replaced with RPMI-1640 (supplemented with 10%
[vol/vol] FCS, 2 mmol/L-glutamine, and 100 U/mL penicillin/0.1
mg/mL streptomycin, Sigma-Aldrich).
2.3 | Labeling of MSC-derived mitochondria
Human and mouse MSCs were transduced with Cell Light BacMam
Mitochondria-GFP (Life Technologies Ltd), according to manufacturer's
instructions. Briefly, MSCs were trypsinized and seeded at a density
100 000 cells (unless otherwise specified) per 35 mm ibitreat ibidi μ-Dish,
high (Thistle Scientific Ltd, Glasgow, UK) and BacMam Mitochondria-
GFP (Life Technologies Ltd) added to the MSC media (DMEM). BacMam
Significance statement
Mesenchymal stromal cells (MSCs) have direct effects on
islet β-cells to improve their insulin secretory function. It is
well established that the generation of ATP and other meta-
bolic coupling factors by mitochondrial metabolism is essen-
tial for nutrient-induced insulin secretion and that impaired
mitochondrial function, and thus reduced oxygen consump-
tion rate, results in defective insulin secretion and reduced
islet β-cell survival. This article reports, for the first time to
the authors' knowledge, that human MSCs transfer their
mitochondria to cocultured human islet β-cells. These find-
ings suggest that the mitochondrial donation capacity of
MSCs should be harnessed to ensure the functional longev-
ity of transplanted human islets in clinical protocols.
MITOCHONDRIAL TRANSFER FROM MSCs TO ISLET β-CELLS 575
mitochondria-GFP is targeted to the mitochondrial matrix pyruvate dehy-
drogenase enzyme complex, ensuring fluorescence labeling of MSC-
derived mitochondria. After 20 hours, the BacMam reagent was
removed, MSCs washed three times in RPMI and expression of the GFP-
transgene confirmed by fluorescence microscopy, prior to setting up
MSC-islet cocultures, as described above.3-5,8
2.4 | Immunostaining of islet β-cells and tunneling
nanotubes
Intact MSC: islet cocultures were immunostained with insulin antibodies
for detection of islet β-cells. Briefly, islet-MSC cocultures were washed
in PBS, fixed in 3.7% (vol/vol) formalin (Sigma-Aldrich) or 2% parafor-
maldehyde where phalloidin staining was included, for 25 minutes,
before permeabilization with 0.3% Triton X-100 (Sigma-Aldrich). Cocul-
tures were incubated for 1 hour at 37C with a polyclonal guinea pig
anti-insulin antibody (1:100, Dako, Ely, UK) or monoclonal mouse anti-
insulin antibody (1:100, Sigma). Tunneling nanotubes (TNTs) were
visualized by staining F-actin with phalloidin (647) and fixed cocultures
washed in PBS prior to incubation for 1 hour at 37C with an Alexa
Fluor594-conjugated donkey anti-guinea pig or anti-mouse secondary
antibody and a goat polyclonal anti-GFP (FITC) secondary antibody
(1:100, Abcam, Cambridge, UK). Cell nuclei were stained with
40,6-diamidino-2-phenylindole (DAPI). Imaging of intact MSC cocultures
was performed using confocal laser scanning microscopy (Nikon A1
inverted). Imaging was started at the MSC-islet interface and upward
through the first 2-3 layers of islet cells. Confocal Z-stack projected
images composed of 10-25× 0.88 μm slices (as specified for each
micrograph) were produced to investigate interactions between MSCs
and cocultured islets. The individual 0.88 μm slices were also analyzed
to confirm the intracellular localization of MSC-derived mitochondria to
islet cells. Twenty-four to 33 individual islets were imaged per group
and analyzed semiquantitatively by a blinded investigator, using FIJI
software (https://fiji.sc/). Specifically, images were stacked, a threshold
set to remove background fluorescence, and the percentage of
remaining GFP signal within the selected islet area was calculated.
2.5 | Islet mitochondrial bioenergetics
The Seahorse extracellular flux analyzer XF24 (Agilent, Cheshire, UK) was
used to measure islet OCR, as per manufacturer's instructions. Briefly, islets
which had been cultured alone or with MSCs3-5,8 were washed in XA basal
media (Agilent) supplemented with 2 mM glucose and 1% FBS, before
hand-picking into groups of 100 islets/500 μL XA basal media, per XF24
well. Islet screens were carefully added to enclose islets in the depression
of the islet microplate. OCR was measured under basal (2 mM) and maxi-
mal (20 mM) glucose concentrations, as well as with drugs acting on the
respiratory chain: oligomycin (ATP synthase inhibitor; 10 μM, Sigma) and
FCCP (uncoupler; 1 μM, Sigma).23 Data were normalized to initial OCR
under basal conditions to account for variations in islet size and are
reported as percentage of basal OCR. Glucose-stimulated respiration was
calculated by dividing the first OCR measurement after injection of 20 mM
glucose by the last basal OCR measurement and multiplying by 100.
2.6 | Islet insulin secretory function
Insulin secretion in vitro was assessed in static incubations of isolated
islets. Islets were preincubated for 2 hours in RPMI containing 2 mM
glucose. Groups of three islets were transferred into 1.5 mL
Eppendorf tubes and incubated at 37C in a bicarbonate-buffered
physiological salt solution, containing 2 mM CaCl2 and 0.5 mg/mL
BSA and either 2- or 20-mM glucose. Samples of the incubation
medium were taken after 1 hour and stored at −20C until assayed
for insulin content using in-house radioimmunoassay.11,24
2.7 | Statistical analysis
Results are expressed as means ± SEM. ANOVA with Bonferroni's mul-
tiple comparison post hoc test was used for comparisons among multi-
ple groups. A Student's t test for comparisons between two groups was
used. A P value of .05 was considered significant. All statistical analysis
was performed using GraphPad Prism version 6.
3 | RESULTS
3.1 | Islet mitochondrial bioenergetics after MSC
coculture
The generation of ATP and other metabolic coupling factors by
mitochondrial metabolism is essential for nutrient-induced insulin
secretion25 and glucose-stimulated OCR is an important predictor
of islet transplantation outcomes.18-20 To determine whether MSCs
induce alterations in islet mitochondrial bioenergetics, we mea-
sured mouse islet OCR using the seahorse XF24 islet respirometry
platform. Islets that had been cocultured with MSCs were sepa-
rated from the MSC monolayer, by gentle pipetting, prior to mea-
surements of islet OCR and glucose-stimulated insulin secretion
(GSIS). Our measurements of islet oxygen consumption demon-
strate improved islet mitochondrial bioenergetics in MSC
cocultured islets (Figure 1A). After a 2-hour preincubation in low
glucose (2 mM), control islets stimulated with 20 mM glucose dem-
onstrated a clear increase in OCR to approximately 1.6-fold their
basal level. In MSC cocultured islets, glucose-stimulated OCR was
increased to twofold of the basal level (Figure 1B). Upon addition
of 10 μM oligomycin (an ATP synthase inhibitor), respiration was
reduced in both control and MSC cocultured islets. Addition of
1 μM FCCP, which induces maximal respiration by uncoupling oxi-
dative phosphorylation from the electron transport chain, caused a
sharp increase in OCR which was more pronounced in MSC
cocultured islets than in control islets. The concentrations of glu-
cose used for basal and glucose-stimulated OCR measurements
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mirror those used for our standard static islet insulin secretion
assays (Figure 1C). As shown in Figure 1C, we consistently observe
an MSC-dependent potentiation of GSIS in both mouse3,4 and
human islets,5,8 and using MSCs derived from multiple tissues
including adipose, BM, and kidney.3-5,8 We now demonstrate that
the MSC-mediated improvements in islet insulin secretory function
are associated with improved islet mitochondrial bioenergetics.
3.2 | Mitochondrial transfer from human MSCs to
human islet β-cells
To assess whether MSCs transfer mitochondria to β-cells in cocultured
islets, we fluorescently tagged the mitochondria in human adipose-
MSCs by transduction with BacMam mitochondria-GFP 1 day prior to
direct contact coculture with human islets. The mitochondrial networks
of MSCs were visualized by fluorescence microscopy, demonstrating
MSCs adhering to the outside perimeter of islets after 1 day of
coculture (Figure 2A, arrowhead). Mitochondria-GFP particles or vesi-
cles, termed hereafter “microvesicles,” were localized to the islet and
rarely associated with surrounding MSCs that were not in close proxim-
ity to neighboring islets. After a 48-hour coculture period, analysis of
three-dimensional (3D) Z-projections of 25× 0.88 μm optical slices
(Figure 2B), from the MSC-islet interface and upward through the first
2-3 layers of islet cells, revealed extensive MSC-derived mitochondrial
transfer to human islet β-cells. Mitochondria-GFP microvesicles, as well
as more diffuse MSC-derived mitochondrial-GFP labeling, were clearly
evident in the majority of β-cells in all islets. A series of consecutive
0.88 μm optical slices (Figure 2C-F) demonstrate the intra-β-cell locali-
zation of the mitochondrial-GFP. Islet non-β-cells were also recipient to
MSC-derived mitochondria (Figure 2C, arrowhead); however, it was
clear that the majority of non-β cells, presumably mainly alpha-, delta-,
or endothelial-cells, within the islet structure were not labeled with
Mitochondria-GFP (Figure 2C, asterisks). These observations are con-
sistent with the physical transfer of MSC-derived mitochondria to
human islet β-cells.
3.3 | Time course of mitochondrial transfer from
human MSCs to human islet β-cells
To determine the time course and extent of mitochondrial transfer
from human adipose-MSCs to cocultured human islets, we quantified
the percentage of islet β-cells that were mitochondria-GFP positive
after 1 (Figure 3A), 2 (Figure 3B), and 3 days (Figure 3C) of coculture.
Mitochondria-GFP could be visualized for at least 25 μm from the
MSC: islet interface into the outer 2-3 layers of islet cells. In some
islets, mitochondria-GFP was evident for at least 40 μm into the 3D
islet architecture. We quantified the percentage of β-cells recipient to
MSC-derived fluorescent mitochondria in individual 0.88 μm slices
(Figure 3D-F) 5, 10, 15, 20, and 25 μm from the MSC: islet interface
after 1, 2, and 3 days of coculture. The percentage of human islet
F IGURE 1 Islet mitochondrial bioenergetics after MSC coculture. A, Oxygen consumption rate (OCR) of mouse islets precultured alone (black
circles) or with mouse adipose MSCs (blue circles), measured using the seahorse XF24 analyzer. OCR was measured under basal (2 mM) and
maximal (20 mM) glucose concentrations, as well as with drugs acting on the respiratory chain: oligomycin (ATP synthase inhibitor; 1 μM, Sigma)
and FCCP (uncoupler; 10 μM, Sigma). OCR was measured using 100 islets per well (n = 8 wells per group; results are representative of three
separate coculture experiments). B, Glucose-stimulated OCR is increased in MSC cocultured islets, 100 islets per well (n = 8 wells per group),
*P < .05 vs islets precultured alone, Student's t test. C, Insulin release at 2 and 20 mmol/L glucose of 10 replicates of triplicate islets cultured for
3 days with mouse adipose MSCs (white bars) or without MSCs (black bars), *P < .05 vs absence of MSCs at the same glucose concentration
(two-way ANOVA with Bonferroni post hoc test). MSC, mesenchymal stromal cells, OCR, oxygen consumption rate
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β-cells that were mitochondria-GFP positive after 1 day of coculture
was variable, ranging from 28.6% to 100%, with a mean of 68.2%
± 4.3% of β-cells containing MSC-derived fluorescent mitochondria.
The percentage of human islet β-cells positive for mitochondria-GFP
after 2 and 3 days of coculture was less variable (57.1%-100% and
58.3%-100%, respectively) and the mean percentage of β-cells con-
taining MSC-derived fluorescent mitochondria increased to 80.9%
± 2.1% and 81.3% ± 2.1% in 2- and 3-day cocultured islets, respec-
tively, as shown in Figure 3G.
3.4 | Mechanism of mitochondrial transfer from
human MSCs to human islets
A number of mechanisms of mitochondrial transfer from MSCs to
recipient cells have been proposed, including TNTs14,15,26 and extra-
cellular vesicles (EVs).15,27,28 TNTs are cytoskeletal-derived ultrafine
structures constituted of F-actin,29 as observed with Phalloidin
staining.14 Filopodia-like protrusions constituted of F-actin could be
visualized extending from the MSC cell body toward islets in direct
contact coculture. We found evidence of these TNT-like structures
between human MSCs and human islets after 1 (Figure 4A), 2 (Fig-
ure 4B), and 3 days (Figure 4C) of coculture. At all time points, MSC-
derived mitochondrial-GFP microvesicles were prevalent both adja-
cent to (Figure 4B, arrowhead) and independent of these actin-based
structures (Figure 4C, arrowhead). The actin cytoskeleton of the islet
cells was also clearly visible at all time points, which complicated visu-
alization of fluorescent mitochondria transfer through the actin-
derived TNTs. However, analysis of individual 0.88 μm slices at each
time point (Figure 4D-F) revealed images consistent with mitochon-
drial transfer through MSC-derived TNTs to neighboring human islet
cells (Figure 4D, arrowhead). Lower magnification images (Figure 2A)
revealed that fluorescent mitochondria-GFP microvesicles were pri-
marily observed where MSCs were in direct contact with β-cells,
suggesting that MSC-islet cell adhesion is required for the formation
of microvesicles and transfer of MSC-derived mitochondria to neigh-
boring β-cells. The abundance of mitochondria-GFP microvesicles,
observed using six separate human islet preparations, suggest that
MSC-derived EVs are another important mechanism of mitochondrial
transfer from MSCs to cocultured human islet β-cells.
F IGURE 2 Mitochondrial transfer from human mesenchymal stromal cells (MSCs) to human islet beta cells. Confocal micrographs showing
representative images of human adipose MSC cocultured human islets. Green indicates MSC-derived BacMam mitochondria-GFP labeling, which
was clearly abundant in the majority of insulin-immunoreactive (red) β-cells. Blue represents DAPI. A, Human adipose MSCs (P5) were seeded and
transduced with BacMam mitochondria-GFP at a density of 50 000 MSCs per 35 mm dish and cocultured with human islets for 1 day before
immunostaining with insulin antibodies, ×20 magnification; scale bar = 50 μm. B-F, Confocal micrographs showing representative images of 2-day
human adipose (P5) MSC cocultured human islets. B, Composite Z-projection of 25× 0.88 μm optical sections of a series of consecutive human
islet slices starting at the MSC: islet interface and upward. C-F, A series of individual consecutive 0.88 μm insulin immunostained human islet
slices starting at the MSC: islet interface and upward, indicating the intra β-cell localization of MSC-derived BacMam mitochondria-GFP. Scale
bar = 10 μm. Images are representative of six separate human MSC: human islet coculture experiments
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3.5 | Mitochondrial transfer is more extensive to
human islets than to mouse islets
We next sought to determine whether mitochondrial transfer occurs
between mouse MSCs and cocultured mouse islets which are more
accessible for experimental investigation. After 2 days, we observed
diffuse MSC-derived mitochondrial-GFP labeling (Figure 5A, arrow-
head) within mouse islets cultured in direct contact with mouse adi-
pose MSCs (Figure 5A,B). However, the defined intra-β-cell
localization and abundance of vesicular mitochondrial-GFP labeling
which we consistently observed in human adipose MSC cocultured
human islets (Figures 2–4) was not evident in mouse islets. Heteroge-
neity in mitochondrial transfer capacity between different MSC tissue
sources have been reported,30 so we also investigated the potential
for mouse BM-MSCs to transfer GFP-labeled mitochondria to neigh-
boring mouse islet cells. After a 3-day coculture period, we visualized
mitochondrial transfer to only a small number of islet cells with
mitochondria-GFP labeling being localized to MSC-derived
F IGURE 3 Time course of mitochondrial transfer from human mesenchymal stromal cells (MSCs) to human islet beta cells. A-C, Composite Z-
projections of 25× 0.88 μm optical sections of a series of consecutive human islet slices starting at the MSC: islet interface and upward. D-F, Individual
0.88 μm insulin immunostained human islet slices (within the first layer [10 μm] of islet cells), indicating the intra β-cell localization of MSC-derived
BacMam mitochondria-GFP. Confocal micrographs are representative images of 1- (A, D), 2- (B, E), and 3-day (C, F) human adipose MSC cocultured
human islets. The percentage of human islet β-cells (insulin immunoreactive: red) that are mitochondria-GFP positive was quantified at each time point.
Blue represents DAPI. Green indicates MSC-derived BacMam mitochondria-GFP labeling. Magnification ×60, scale bar = 10 μm. G, Quantification of
the percentage of β-cells recipient to MSC-derived mitochondria in 0.88 μm slices 5, 10, 15, 20, and 25 μm from the MSC: islet interface after 1, 2, and
3 days of coculture, *P < .05 vs 1-day MSC cocultured islets, one-way ANOVA with Bonferroni's post hoc test
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cytoplasmic extensions into the outer layer of islet cells at the MSC-
islet interface, as shown in composite Z-projection micrographs
(Figure 5C, arrowhead) and individual 0.88 μm optical slices
(Figure 5D). More diffuse mitochondria-GFP labeling was also visual-
ized in proximity to the MSC-derived cytoplasmic extensions
(Figure 5D, arrowhead). To determine whether human MSCs are more
effective mitochondria donors than mouse MSCs we cocultured
mouse islets with mitochondrial GFP-labeled human adipose MSCs.
3D Z-projections of 25× 0.88 μm optical slices starting at the MSC-
islet interface and upward through the outer 2-3 layers of mouse islet
cells (Figure 5E), as well as analysis of individual 0.88 μm slices
(Figure 5F) did not reveal extensive mitochondrial transfer from
human adipose MSCs to mouse islets. Thus, the lack of extensive
mitochondria transfer to mouse β-cells is unlikely to be due to the
mitochondrial donation capacity of MSCs, but most likely reflects dif-
ferences between the ability of mouse and human β-cells to act as
mitochondrial recipients.
3.6 | Enhanced mitochondrial transfer to hypoxia-
exposed mouse islets
Reports of mitochondria transfer in other tissues are often in models
of ischemic or inflammatory disease,13-17 consistent with recipient
cells responding to cellular stressors by signaling to MSCs to initiate
mitochondrial transfer. Isolated human islets are less robust than
mouse islets and express a hypoxic molecular signature during the
in vitro culture period prior to transplantation,31 which is not seen in
isolated mouse islets. To determine whether hypoxia influences the
extent of mitochondrial transfer from MSCs to islets, we exposed
mouse islets to hypoxia (1% oxygen) for 16 hours prior to coculture
with mouse or human MSCs. Control mouse islets cultured
under normoxic conditions (20% oxygen) demonstrated diffuse
mitochondrial-GFP labeling (Figure 6A,B), as shown previously in
Figure 5. In contrast, the extent of mitochondrial transfer to hypoxic
mouse islets was more extensive, as shown in 3D Z-projection
micrographs (Figure 6C). The insulin immunostaining intensity was
notably weaker in hypoxic mouse islets, as expected, but 0.88 μm
islet slices (Figure 6D) confirmed the intracellular localization of
MSC-derived mitochondria within islet cells, including insulin-
positive β-cells (Figure 6D, arrowhead). Semiquantitative analysis of
mitochondria-GFP labeling was assessed by calculating the percent-
age of the area within an islet containing GFP fluorescence. After
72 hours of coculture, 0.32% ± 0.06% of the islet area of control
islets (normoxia) contained mitochondria-GFP labeling, which was
increased to 1.22% ± 0.21% in hypoxia pre-exposed islets
(Figure 6E). Mitochondria-GFP was evident within phalloidin-
positive structures localized to β-cells (Figure 6F, arrowhead, and
F IGURE 4 Mechanism of mitochondrial transfer from human mesenchymal stromal cells (MSCs) to human islets. A-C, Composite Z-projections of
20× 0.88 μm optical sections of a series of consecutive human islet slices starting at the MSC: islet interface and upward. D-F, Individual 0.88 μm
human islet slice, within the first layer (10 μm) of islet cells. Confocal micrographs show representative images of 1- (A, D), 2- (B, E), and 3-day (C, F)
human adipose (P5) MSC cocultured human islets. Green indicates MSC-derived BacMam mitochondria-GFP labeling. Red represents insulin
immunostained β-cells. Cyan represents phalloidin staining of F-actin. Blue represents DAPI. Magnification ×60, scale bar= 10 μm
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Figure 6G), consistent with mitochondrial transfer through TNTs to
hypoxic mouse islets.
4 | DISCUSSION
In other tissues, mitochondrial transfer from MSCs is associated with
the rescue of metabolic viability in recipient cells which have been
subjected to ischemic and inflammatory stresses13-17 but, to our
knowledge, this is the first report of mitochondria transfer into
insulin-secreting β-cells in mouse and human islets. β-cells are meta-
bolically active and use mitochondrial ATP generation to couple eleva-
tions in circulating glucose to β-cell depolarization and the exocytotic
release of insulin.32 Islet mitochondria are particularly vulnerable to
hypoxic stresses during the isolation, purification, and in vitro culture
of islets, and impaired mitochondrial mass and/or function results in
defective insulin secretion and reduced β-cell survival.33 Accordingly,
islet mitochondrial OCR is a key predictor of islet transplantation out-
come.18-20 Numerous studies have demonstrated that MSCs improve
β-cell function in vitro and in vivo and our observations suggest that
the transfer of functional mitochondria may be an important mecha-
nism underlying these beneficial effects.
Thus, we consistently observed MSC-derived mitochondria-GFP
localized within >80% of human β-cells located in the outer 25 μm of
each islet and at the region of direct contact with cocultured human
MSCs. Mitochondrial-GFP was also observed penetrating as far as
40 μm into the 3D islet structure. The average islet diameter is
approximately 150 μm,34 so our observations suggest that up to 30%
of β-cells are recipient to MSC-derived mitochondria, sufficient to
induce a functional phenotype in the intact islets. The transfer of
mitochondria to human β-cells increased during the first two days of
coculture with no further increase thereafter, consistent with our pre-
vious reports that MSC coculture induces a significant potentiation of
insulin secretion after 2 and 3 days, but not prior to this.5,11
Our measurements of mitochondria transfer from mouse MSCs to
cocultured mouse islets showed less extensive transfer than that seen
in our studies using human cells. This is unlikely to reflect an inability of
mouse MSCs to transfer mitochondria. MSCs are heterogeneous in
their expression of soluble bioactive molecules, and their functional
characteristics, including mitochondrial transfer capacity,30 can vary
depending upon tissue source, species, and passage number.35 How-
ever, our measurements consistently demonstrated less extensive
mitochondrial-GFP labeling in mouse islets cocultured with mouse BM-
MSCs, mouse adipose MSCs, and human adipose MSCs when com-
pared to human islets, suggesting that the species variation was not
due to the superior functional capacity of human adipose MSCs to
donate their mitochondria to neighboring islet cells. The most likely
explanation for the more extensive mitochondrial transfer to human
islets is that the level of cellular stress in isolated human islets is much
greater than that of isolated mouse islets, partly because of the differ-
ences in the isolation processes and partly because of donor differ-
ences. Human islets experience a prolonged cold ischaemia time during
the isolation process and they express characteristic hypoxia inducible
F IGURE 5 Mitochondrial transfer is more extensive to human islets
than to mouse islets. Confocal micrographs showing representative
images of mesenchymal stromal cells (MSCs) transduced with BacMam
mitochondria-GFP, seeded at a density of 100 000 MSCs per 35 mm
Petri dish, prior to coculture with mouse islets. A,B, P8 mouse adipose
MSC 2-day cocultured mouse islets. Green indicates diffuse MSC-
derived BacMam mitochondria-GFP labeling in a composite Z-projection
of 20× 0.88 μm optical sections of a series of consecutive mouse islet
slices starting at the MSC: islet interface and upward (A). B, A single
0.88 μm optical section within the outer layer (first 10 μm) of mouse islet
cells. A,B, Magnification ×60, scale bar = 10 μm. C,D, Green indicates
mouse bone marrow (BM) (P8) MSC-derived BacMam mitochondria-
GFP labeling, demonstrating evidence of mitochondrial transfer through
mouse BMMSC-derived cytoplasmic extensions into the outer layer of
mouse islets, with more diffuse mitochondria-GFP labeling in the
surrounding insulin-immunoreactive (red) β-cells also evident. Blue
represents DAPI. C, Composite Z-projection of 10× 0.88 μm optical
sections of a series of consecutive mouse islet slices starting at the MSC:
islet interface and upward. D, A single 0.88 μm optical section within the
outer layer (first 10 μm) of mouse islet cells. C,D, Magnification ×20,
scale bar = 20 μm. E,F, Green indicates human adipose (P5) MSC-derived
BacMam mitochondria-GFP labeling in a composite Z-projection of
25× 0.88 μm optical sections (E) of a series of consecutive mouse islet
slices starting at the MSC: islet interface and upward. F, A single 0.88 μm
optical section within the outer layer (first 10 μm) of mouse islet cells,
demonstrating less extensive MSC-derived mitochondrial transfer to
mouse insulin-immunoreactive (red) β-cells compared with that in human
islet β-cells (as represented in Figures 2–4). E,F, Magnification ×60, scale
bar = 10 μm. These experiments were replicated with three separate
mouse islet isolations
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factor-1α regulated genes, with a gene expression profile following cul-
ture under normoxic conditions (20% O2) which resembles that of
mouse islets exposed to hypoxia (1% O2).
31 Thus, human islets are sub-
jected to more extreme cellular stressors than mouse islets which may
induce “danger signals”36 for MSCs, initiating the donation of MSC-
derived mitochondria to human β-cells. Our observations of increased
MSC-mediated mitochondria transfer to hypoxia-exposed mouse islets
are consistent with this and suggest that MSCs are most effective in
supporting the secretory function of compromised β-cells. Transfer of
mitochondria from MSCs into β-cells may explain the observed effects
of MSC coculture to increase islet OCR in response to elevated glucose.
The increased flux of oxidative phosphorylation may, in turn, explain
the effects of MSCs to enhance GSIS which we have reported
previously,3-5,8,11 and confirmed in the current study.
Differences in islet donors may also influence experimental out-
comes. Human islets are isolated from pancreases harvested from
heart-beating, brain-dead donors and factors such as age, BMI, and
duration of brain death have been shown to impact upon human islet
isolation success and on islet function in vitro.37,38 In contrast, mouse
islets are isolated rapidly from healthy, lean, genetically homogenous,
young animals. MSCs are reported to transfer mitochondria to cells
deficient in mtDNA but not to otherwise healthy cells,16,39 and previous
studies have shown an age-related decline in mtDNA copy number in
isolated human islets.40 Most of our human islet donors were in middle
age, in contrast to the relatively young 8- to 12-week-old mouse
donors used in most islet studies. Differences in islet architecture41,42
and differential expression of cell adhesion molecules may also contrib-
ute to differences in mitochondria transfer. For example, transfer of
MSC-derived mitochondria to lipopolysaccharide-injured alveolar epi-
thelial cells was dependent upon connexin 34 (Cx43)-mediated alveolar
attachment15 and human and mouse islets differ in their expression of
adhesion molecules and gap junctional complex (GJC) components,
including connexins.43 Our imaging studies have demonstrated the
presence of mitochondria-GFP microvesicles predominantly where
MSCs are in direct contact with human islets, suggesting that islet-MSC
contact is required for the transfer of mitochondria and subsequent
improvements in islet insulin secretory function. In accordance, our pre-
vious studies have demonstrated that indirect transwell MSC-islet
F IGURE 6 Enhanced mitochondrial transfer to hypoxia-exposed mouse islets. Confocal micrographs showing representative 3-day
cocultured mouse islets, which were exposed to hypoxia (1% O2) for 16 hours before coculturing with mesenchymal stromal cells (MSCs). Green
indicates MSC-derived BacMam mitochondria-GFP labeling, and red indicates insulin immunostaining of β-cells and blue represents DAPI (A-D
and F-G). Cyan represents phalloidin (F,G) staining of F-actin, indicative of TNTs. A,C, Composite Z-projection micrographs of 25× 0.88 μm
optical sections of a series of consecutive mouse islet slices starting at the MSC: islet interface and upward, in control mouse islets cultured under
normoxia (A) and hypoxia pre-exposed islets (C), subsequently cocultured with mouse bone marrow (BM) MSCs. Magnification ×60, scale
bars = 10 μm. B,D, Individual 0.88 μm insulin immunostained mouse islet slices, within the outer layer (first 10 μm) of cells of islets cultured under
normoxia (B) and hypoxia pre-exposed islets (D). Magnification ×60, scale bars = 25 μm. E, Semiquantitative analysis of mitochondrial transfer
determining the percentage of each islet area occupied by BacMam mitochondrial-GFP labeling in 24-33 separate islets, *P < .001 vs normoxia
cultured islets, Student's t test. Data presented are representative of three independent experiments. F,G, Human adipose MSC cocultured mouse
islets pre-exposed to hypoxia. Phalloidin staining of F-actin in a composite Z-projection of 25× 0.88 μm optical sections of a series of consecutive
insulin immunostained mouse islet slices (F) and an individual 0.88 μm slice (G) demonstrating BacMam mitochondrial GFP-labeling within F-actin
based TNT-like ultrastructures. Magnification ×60, scale bars = 5 μm
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coculture does not improve GSIS, in contrast to the robust improve-
ments we have consistently observed using direct contact coculture of
islets with MSCs. 3-5 Several mechanisms of mitochondria transfer from
MSCs to injured tissues have been proposed, including microvesicles,
TNTs,14,26,44 mitochondrial extrusion, and cytoplasmic fusion with the
recipient cells (reviewed in Reference 36). In a mouse model of acute
lung injury, mitochondrial donation to alveolar epithelial cells was
dependent on the stabilization of cell: cell adhesion via the establish-
ment of Cx43-containing GJCs and subsequent formation of
mitochondria-transferring TNTs.15 Mitochondria-containing micro-
vesicles were shown to bud from both the ends of TNTs and from the
MSC cell body, with engulfment of some of the microvesicles by the
epithelial cells. We observed extensive MSC-derived mitochondrial-
GFP labeling 25-40 μm (3-4 islet cell layers) into the 3D human islet
architecture, consistent with the notion of organelle transfer through
TNTs,29 which have lengths of several cell diameters.45 We also
detected TNT-like structures, composed of F-actin, spanning between
the MSCs and neighboring β-cells. MSCs shed a diverse population of
EVs, including mitochondria-containing microvesicles (0.1-1 μm in diam-
eter).28 MSC-derived EVs recapitulate the capacity of MSCs to transfer
their mitochondria to recipient cells in models of lung injury28 and the
transfer of partially depolarized mitochondria from MSCs experiencing
oxidative stress to cocultured macrophages enhances MSC survival
whilst restoring mitochondrial bioenergetics in the recipient cells.46
Together, the vesicular morphology of the mitochondrial-GFP labeling
within human β-cells and the depth of penetration of the mitochondria
transfer into the 3D islet structure are consistent with a mechanism
involving both TNTs and microvesicles, as described previously.15
5 | CONCLUSION
In conclusion, MSCs transfer mitochondria to islet β-cells during in vitro
coculture, and this correlates with increased β-cell mitochondrial oxy-
gen consumption and enhanced glucose-induced insulin secretion.
Mitochondrial transfer from human MSCs to human islets is more
extensive than from mouse MSCs to mouse islets, most likely because
isolated human islets are exposed to more extreme cellular stressors
which initiate mitochondria transfer to human islets. Ensuring optimal
β-cell mitochondrial mass and bioenergetics through MSC-mediated
mitochondria transfer therefore offers a novel strategy for improving
the outcomes of clinical islet transplantation as a therapy for T1D.
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